TotalFinaElf sells 2.3% of Sanofi-Synthélabo
23-Apr-2001
TotalFinaElf announces the sale of 2.3% of the share capital of Sanofi-Synthélabo, or 16.7 million shares held by Elf Aquitaine, to be placed with institutional investors.
This sale is in line with the strategy announced by the Group.
Elf Aquitaine's 32.7% ownership of the share capital of Sanofi-Synthélabo before this transaction is reduced to 30.4% following the sale.
Most read news
Organizations
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.